Decision of the EEA Joint Committee No 106/2021 of 19 March 2021 amending Annex I... (22024D0092)
    EU - Internationale Abkommen
    2024/92
    18.1.2024

    DECISION OF THE EEA JOINT COMMITTEE No 106/2021

    of 19 March 2021

    amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/92]

    THE EEA JOINT COMMITTEE,
    Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
    Whereas:
    (1) Commission Implementing Regulation (EU) 2020/1685 of 12 November 2020 amending Regulation (EU) No 37/2010 to classify the substance bupivacaine as regards its maximum residue limit  ( 1 ) is to be incorporated into the EEA Agreement.
    (2) Commission Implementing Regulation (EU) 2020/1712 of 16 November 2020 amending Regulation (EU) No 37/2010 to classify the substance lidocaine as regards its maximum residue limit  ( 2 ) is to be incorporated into the EEA Agreement.
    (3) Annex II to the EEA Agreement should therefore be amended accordingly,
    HAS ADOPTED THIS DECISION:

    Article 1

    The following indents are added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the EEA Agreement:
    ‘-
    32020 R 1685 : Commission Implementing Regulation (EU) 2020/1685 of 12 November 2020 ( OJ L 379, 13.11.2020, p. 44 ),
    - 32020 R 1712 : Commission Implementing Regulation (EU) 2020/1712 of 16 November 2020 ( OJ L 384, 17.11.2020, p. 3 ).’

    Article 2

    The texts of Implementing Regulations (EU) 2020/1685 and (EU) 2020/1712 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

    Article 3

    This Decision shall enter into force on 20 March 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

    Article 4

    This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
    Done at Brussels, 19 March 2021.
    For the EEA Joint Committee
    The President
    Clara GANSLANDT
    ( 1 )    OJ L 379, 13.11.2020, p. 44 .
    ( 2 )    OJ L 384, 17.11.2020, p. 3 .
    ( *1 )   No constitutional requirements indicated.
    ELI: http://data.europa.eu/eli/dec/2024/92/oj
    ISSN 1977-0677 (electronic edition)
    Markierungen
    Leseansicht
    Verwendung von Cookies.

    Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

    Akzeptieren